Meso-Inositol Hexanicotinate Induced Protection against Experimental Anoxia and Oedema
Open Access
- 1 November 1972
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 1 (1) , 13-14
- https://doi.org/10.1177/030006057200100104
Abstract
It is shown that Meso-Inositol Hexanicotinate (MIHN; Hexopal) inhibits experimentally induced oedema of the paw in rats and that mice exposed to hypoxic atmospheres (4% oxygen) show significant increase in survival time if pre-dosed with MIHN. The protection against oedema and hypoxia conferred by MIHN in experimental animals may well be related to the mode of action of the substance in man, and particularly could explain the usefulness of MIHN in the treatment of cerebral and peripheral atherosclerosis.Keywords
This publication has 3 references indexed in Scilit:
- Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliteransAmerican Heart Journal, 1970
- Microcirculatory aspects of atherogenesis, thrombogenesis, and antiatheroscleroticsAmerican Heart Journal, 1968
- Enzymic Processes and Vascular Changes in the Skin Radiation ReactionThe British Journal of Radiology, 1966